Exclusive: MDO to restrict cover for medicinal cannabis prescribers from next week
MDA National has deemed medicinal cannabis prescribing an 'unusual' practice under its latest indemnity policy.
Doctors who prescribe medicinal cannabis “as a standalone practice” will need to undergo assessment from MDA National to confirm their cover as part of its new indemnity policy that starts on 1 July.
The medical defence organisation has added standalone cannabis prescribing to its “unusual practice” list, alongside stem cell therapies and human growth hormone prescribing.
